Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Ventyx Biosciences, Inc. (VTYX)

Compare
1.0000
-0.0600
(-5.66%)
At close: April 3 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
148,450
148,450
207,994
113,136
67,147
Operating Income
-148,450
-148,450
-207,994
-113,136
-67,147
Net Non Operating Interest Income Expense
13,416
13,416
15,074
4,669
-21
Other Income Expense
-88
-88
-42
41
-16,578
Pretax Income
-135,122
-135,122
-192,962
-108,426
-83,746
Net Income Common Stockholders
-135,122
-135,122
-192,962
-108,426
-85,298
Diluted NI Available to Com Stockholders
-135,122
-135,122
-192,962
-108,426
-85,298
Basic EPS
-2.35
-1.97
-3.30
-2.07
-6.65
Diluted EPS
-2.35
-1.97
-3.30
-2.07
-6.65
Basic Average Shares
65,541.8210
68,478.1720
58,542.9740
52,471.0030
12,825.5980
Diluted Average Shares
65,541.8210
68,478.1720
58,542.9740
52,471.0030
12,825.5980
Total Operating Income as Reported
-148,450
-148,450
-207,994
-113,136
-67,147
Total Expenses
148,450
148,450
207,994
113,136
67,147
Net Income from Continuing & Discontinued Operation
-135,122
-135,122
-192,962
-108,426
-83,746
Normalized Income
-135,122
-135,122
-192,962
-108,426
-72,695
Interest Income
13,416
13,416
15,074
4,669
78
Interest Expense
--
--
--
--
99
Net Interest Income
13,416
13,416
15,074
4,669
-21
EBIT
-148,450
-148,450
-207,994
-113,136
-83,647
EBITDA
-147,102
-147,102
-207,053
-112,666
-83,617
Reconciled Depreciation
1,348
1,348
941
470
30
Net Income from Continuing Operation Net Minority Interest
-135,122
-135,122
-192,962
-108,426
-83,746
Total Unusual Items Excluding Goodwill
--
--
--
--
-11,051
Total Unusual Items
--
--
--
--
-11,051
Normalized EBITDA
-147,102
-147,102
-207,053
-112,666
-72,566
12/31/2021 - 10/21/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HLVX HilleVax, Inc.
1.4500
-3.33%
 
SPRO Spero Therapeutics, Inc.
0.6240
-11.61%
 
KROS Keros Therapeutics, Inc.
10.28
+2.39%
 
ASMB Assembly Biosciences, Inc.
9.31
-1.69%
 
RPTX Repare Therapeutics Inc.
1.0500
-1.87%
 
CLRB Cellectar Biosciences, Inc.
0.2932
-2.95%
 
PMVP PMV Pharmaceuticals, Inc.
0.9950
-0.50%
 
EPIX ESSA Pharma Inc.
1.5800
0.00%
 
THRD Third Harmonic Bio, Inc.
3.5700
+0.56%
 
IPSC Century Therapeutics, Inc.
0.4590
-2.28%